Biogen Stock Explodes Higher After Alzheimer’s Drug Succeeds In Final-Phase Test

Biogen stock exploded higher Wednesday — bringing shares of other Alzheimer’s plays with it — after its experimental treatment succeeded in a final-phase test. X The results are sorely needed fo...